Financial News

ETFMG Treatments Testing & Adv ETF (NY: GERM )

19.16 UNCHANGED

Last Price Updated: 8:00 PM EDT, Sep 5, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ETFMG Treatments Testing & Adv ETF

Mpox Variant Sparks Global Concern As Europe, China Ramp Up Screening

August 19, 2024

Increased screening for deadly new version of mpox is seen in Europe and China. More imported cases are expected. New vaccines are being developed.

Via Benzinga

FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch

August 19, 2024

The FDA may approve updated COVID-19 vaccines this week to combat recent strains as the country endures a significant summer outbreak.

Via Benzinga

Topics ETFs

Exposures COVID-19 Product Safety

Biotech ETFs That Outperformed Last Week

December 20, 2021

Though the broad U.S. market saw a tumultuous ride last week with most of the sectors in red, biotechnology was the biggest gainer.

Via Talk Markets

5 Best Sector ETFs of November

December 01, 2021

Though the broad markets ended the month in red, a few sector ETFs performed remarkably well.

Via Talk Markets

Novavax Stock Is a Buy for Long-Term Investors on Its Pipeline Alone

November 01, 2021

After the formidable run, NVAX stock has come under significant pressure, but between its pipeline and its Covid vaccine, it is a dip buy.

Via InvestorPlace

ETFs to Buy on Most-Bullish Wall Street Outlook in Two Decades

August 16, 2021

Investors seeking to tap the most bullish view could consider the following ETFs. These funds are showing solid strength this year and will likely continue their momentum going forward.

Via Talk Markets

Tuesday Talk: Summer Stock

July 06, 2021

Summer is in full swing and as Q2 ends and its earning season begins it is time to take stock of 1H 2021 and see where things may be heading in 2H.

Via Talk Markets

Moderna ETFs To Rise On Positive COVID-19 Vaccine Updates

July 03, 2021

The competition to come up with a vaccine is opening up near-term opportunities, making the biotech sector a prospective space for investments. Therefore, we discuss a few ETFs that provide exposure to...

Via Talk Markets

Exposures COVID-19

Moderna Stock Moves After Q1 Print: Technical Levels For The COVID-19 Vaccine Play

May 06, 2021

Moderna Inc. (NASDAQ: MRNA) shares gapped down Thursday and have since gained back some ground. Moderna reported first-quarter earnings Thursday of $2.84 per share, beating the...

Via Benzinga

Exposures COVID-19

5 Sector ETFs That Crushed The Market In April

May 01, 2021

Rapid vaccinations, progress on vaccines and expanded stimulus continued to drive stocks higher; the USA is expected to become the engine of the global economy this year. Here, 5 ETFs that should...

Via Talk Markets

Topics Economy

Exposures Economy

5 Niche ETFs Dominating the Current Market Rally

April 20, 2021

Wall Street has been enjoying continued ascent with the S&P 500 and Dow Jones hitting a series of record highs.

Via Talk Markets

Topics Stocks

Exposures US Equities

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Financial News

ETFMG Treatments Testing & Adv ETF (NY: GERM )

All News about ETFMG Treatments Testing & Adv ETF

Popular Pages